Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression

Hepatitis C virus (HCV) represents a major global health problem for which a vaccine is not available. Modified vaccinia virus Ankara (MVA)-HCV is a unique HCV vaccine candidate based in the modified vaccinia virus Ankara (MVA) vector expressing the nearly full-length genome of HCV genotype 1a that...

Descripción completa

Detalles Bibliográficos
Autores principales: Q. Marín, María, Pérez, Patricia, Gómez, Carmen E., S. Sorzano, Carlos Óscar, Esteban, Mariano, García-Arriaza, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116028/
https://www.ncbi.nlm.nih.gov/pubmed/30096846
http://dx.doi.org/10.3390/v10080414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116028/
https://www.ncbi.nlm.nih.gov/pubmed/30096846
http://dx.doi.org/10.3390/v10080414

Ejemplares similares